Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

NCT00002887 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: etoposide
DRUG: hydroxyurea
DRUG: vinblastine sulfate
DRUG: vindesine
DRUG: vinorelbine tartrate
PROCEDURE: drug resistance inhibition treatment

Sponsor

Ottawa Regional Cancer Centre